12:00 AM
 | 
Aug 15, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Caldolor ibuprofen regulatory update

Cumberland disclosed in its 2Q11 earnings that marketing partner Alveda Pharmaceuticals Inc. (Toronto, Ontario) submitted a NDS to Health Canada...

Read the full 80 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >